Clinical Trials for Metastatic Breast Cancer

Find clinical trials for metastatic breast cancer. Discover research opportunities and treatment options in your area.

165 Active Trials Found

Showing 165 trials on this page

Page 4 of 9

Prospective Study, Assessing Potential Interest of [68Ga]Ga-PentixaFor PET/CT in Metastatic Triple Negative Breast Cancer Patients

NCT ID: NCT06962163

This clinical trial is investigating a new imaging method called [68Ga]Ga-PentixaFor PET/CT, which may help doctors better understand and treat metastatic triple-negative breast cancer (TNBC). TNBC...

Not yet recruiting

Phase: NA Type: interventional

Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)

NCT ID: NCT05660083

This clinical trial is investigating a new treatment approach for patients with a specific type of breast cancer called HER2-negative metaplastic breast cancer, particularly those whose cancer has ...

Phase: PHASE2 Type: interventional Locations: Houston, Texas, United States, Houston, Texas, United States +1 more

Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer

NCT ID: NCT06795529

This clinical trial is focused on improving the quality of care for patients with metastatic breast cancer, especially those who are nearing the end of life. Many patients in this situation struggl...

Not yet recruiting

Phase: NA Type: interventional Locations: Durham, North Carolina, United States, Boston, Massachusetts, United States +1 more

Definitive Radiation for High-Risk Spine Metastases

NCT ID: NCT06165419

This clinical trial is exploring a treatment option for patients with cancer that has spread to the spine. Specifically, it is looking at whether using a targeted type of radiation therapy, known a...

Phase: PHASE2 Type: interventional Locations: Stony Brook, New York, United States

A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer

NCT ID: NCT04683679

This clinical trial is investigating whether adding two medications, pembrolizumab and olaparib, to standard radiation therapy can provide a safer and more effective treatment for women with advanc...

Phase: PHASE2 Type: interventional Locations: New York, New York, United States, Basking Ridge, New Jersey, United States +5 more

Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer

NCT ID: NCT06409390

This clinical trial is studying a new way to use existing breast cancer medications to treat women with metastatic breast cancer, which is cancer that has spread beyond the breast. The goal is to f...

Phase: EARLY_PHASE1 Type: interventional Locations: Tampa, Florida, United States

Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast Cancer

NCT ID: NCT05563220

This clinical trial is studying a new medication called elacestrant, which is being tested in combination with other treatments for patients with advanced or metastatic breast cancer that is positi...

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Jacksonville, Florida, United States +115 more

FDG-PET/CT vs. CT for Monitoring Metastatic Breast Cancer

NCT ID: NCT06877949

The MONITOR-RCT clinical trial is studying whether a special imaging technique called FDG-PET/CT can help doctors better monitor patients with metastatic breast cancer compared to the standard CT s...

Phase: NA Type: interventional Locations: Copenhagen, , Denmark, Odense, , Denmark +9 more

Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer

NCT ID: NCT03824145

The clinical trial titled "Every Day Counts" is designed to study how lifestyle choices, like diet and physical activity, affect women with metastatic breast cancer (MBC). Researchers want to learn...

Phase: NA Type: interventional Locations: Maywood, Illinois, United States, Milwaukee, Wisconsin, United States

Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients

NCT ID: NCT03449238

This clinical trial is studying a treatment approach for women with metastatic breast cancer that has spread to the brain. Participants will receive a medication called pembrolizumab, which helps t...

Phase: PHASE1 Type: interventional Locations: New York, New York, United States, New York, New York, United States +1 more

Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008

NCT ID: NCT03275311

This clinical trial is examining how the treatment of metastatic breast cancer has changed over time, specifically since 2008. The study aims to gather real-life data from patients' medical records...

Type: observational Locations: Rouen, , France, Nice, , France +18 more

PIK3CA/PTEN-altered Advanced Breast Cancer Treated With MEN1611 Monotherapy or in Combination With Eribulin

NCT ID: NCT05810870

The SABINA clinical trial is studying a new treatment approach for patients with advanced or metastatic breast cancer that has specific genetic alterations (PIK3CA or PTEN alterations). The trial i...

Phase: PHASE2 Type: interventional Locations: Madrid, , Spain, Barcelona, , Spain +12 more

T-DXd Therapy for HER2-low Breast Cancer Patients With Brain Metastases

NCT ID: NCT06048718

The TUXEDO-4 clinical trial is studying a new treatment called Trastuzumab-Deruxtecan (T-DXd) for patients with breast cancer that has spread to the brain and is classified as HER2-low. This trial ...

Phase: PHASE2 Type: interventional Locations: Madrid, , Spain, Valencia, , Spain +11 more

Ribociclib&Belinostat In Patients w Metastatic Triple Neg Breast Cancer & Recurrent Ovarian Cancer w Response Prediction By Genomics

NCT ID: NCT04315233

This clinical trial is exploring a combination of two medications, ribociclib and belinostat, to see how well they work together to treat patients with advanced triple-negative breast cancer and re...

Phase: PHASE1 Type: interventional Locations: Salt Lake City, Utah, United States, Fairfax, Virginia, United States

A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer

NCT ID: NCT06099769

This clinical trial is exploring the effectiveness of a drug called enzalutamide, both on its own and in combination with another drug called mifepristone, for treating advanced breast cancer that ...

Phase: PHASE2 Type: interventional Locations: Birmingham, Alabama, United States, New York, New York, United States +13 more

Metastasis-directed Therapy for Oligometastases of Breast Cancer

NCT ID: NCT06135714

The OLIGAMI trial is a clinical study aimed at exploring a new treatment approach for patients with oligometastatic breast cancer, which means their cancer has spread to a limited number of places ...

Phase: PHASE3 Type: interventional Locations: Tokyo, , Japan

HER-2 B Cell Peptide Vaccine

NCT ID: NCT06414733

This clinical trial is investigating a new type of vaccine therapy to help patients with metastatic solid tumors, including certain types of breast and gastrointestinal cancers. The study aims to f...

Phase: PHASE1 Type: interventional Locations: Indianapolis, Indiana, United States, Indianpolis, Indiana, United States

Phase 1 Trial of SYNC-T - Immunotherapy for Patients With Advanced/Metastatic Solid Tumors

NCT ID: NCT05544240

This clinical trial is studying a new treatment called SYNC-T, which is an immunotherapy designed to help patients with advanced or metastatic solid tumors, including types like metastatic breast c...

Phase: PHASE1 Type: interventional Locations: Mexico City, , Mexico

PRE-I-SPY Phase I/Ib Oncology Platform Program

NCT ID: NCT05868226

The PRE-I-SPY trial is a research study designed to test new treatments for various types of breast cancer, including HER2-positive and triple-negative breast cancer. The goal of this trial is to f...

Phase: PHASE1 Type: interventional Locations: Tampa, Florida, United States, Houston, Texas, United States +5 more

Bortezomib Plus Cisplatin in Recurrent or Metastatic Breast Cancer

NCT ID: NCT06900647

This clinical trial is investigating a new treatment for women with recurrent or metastatic breast cancer, which is cancer that has come back or spread beyond the breast. The study is specifically ...

Phase: PHASE1 Type: interventional Locations: Guangzhou, , China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions